Name: Novartis AG (NVS) Financial Statements
Creator: FinSpry

Novartis Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

Novartis AG income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	54.81	51.72	46.66	43.46	43.97	49.90	95.00	46.10
Cost of Revenue	13.69	12.83	12.47	11.58	11.39	-15.12	-14.43	14.51
Gross Profit	41.12	38.90	34.19	31.88	32.58	34.78	34.25	31.59
Operating Expenses
Research & Development	10.74	10.02	11.37	9.17	8.26	8.98	9.40	8.49
Selling, General & Administrative	13.31	12.57	12.52	12.19	12.76	14.20	14.37	13.72
Operating Expenses	24.05	24.35	24.50	23.93	21.62	26.37	27.20	23.19
Operating Income	17.07	14.54	9.69	7.95	10.96	55.83	53.37	8.40
Other Income/Expense
Interest Income	0.37	0.57	0.63	0.38	0.07	0.09	0.00	0.29
Interest Expense	1.19	1.01	-0.86	0.80	-0.79	-0.87	0.00	0.97
Other Income/Expense	-0.64	-0.22	-0.23	-0.20	-0.03	-10.49	-2.69	6.44
Income
Income Before Tax	16.44	13.64	9.12	7.18	24.53	9.88	8.94	14.10
Income Tax Expense	2.40	1.70	-0.55	1.13	1.63	1.81	-5.35	1.30
Net Income	14.06	11.94	15.95	6.96	24.02	8.07	81.53	12.61
Net Income - Continuous Operations	14.06	11.94	8.57	6.05	22.91	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	6.28	0.91	1.11	0.00	0.00	0.00
EBITDA	22.99	20.72	9.91	14.68	15.63	17.21	9.79	20.28
EBIT	19.01	14.65	9.91	7.98	10.96	10.75	9.79	15.07
Depreciation & Amortization	5.35	6.07	7.92	6.71	4.67	-0.33	-0.31	0.00
Earnings Per Share
Basic EPS	7.00	6.00	7.00	3.00	11.00	4.00	5.00	5.00
Diluted EPS	7.00	6.00	7.00	3.00	11.00	4.00	5.00	5.00
Basic Shares Outstanding	1.94	2.02	2.08	2.18	2.24	2.28	2.29	2.32
Diluted Shares Outstanding	1.96	2.04	2.09	2.20	2.26	20.35	16.11	2.34